| 06/17/2026 3:45 PM | Odyssey Therapeutics (1882782) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/17/2026 3:45 PM | Odyssey Therapeutics (1882782) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 06/05/2026 9:13 AM | FMR LLC (315066) Filed by Odyssey Therapeutics (1882782) Subject | Form SCHEDULE 13G | |
| 05/18/2026 7:20 PM | Lightspeed Venture Partners XV-B (0) Ignite Odyssey Therapeutics (1882782) Subject | Form SCHEDULE 13G | |
| 05/18/2026 5:29 PM | Odyssey Therapeutics (1882782) Subject SR ONE CAPITAL MANAGEMENT, LLC (1853723) Filed by | Form SCHEDULE 13D | |
| 05/18/2026 3:06 PM | Odyssey Therapeutics (1882782) Subject TPG GP A, LLC (1903793) Filed by | Form SCHEDULE 13D | |
| 05/15/2026 1:58 PM | Jeito II S.L.P. (2134396) Filed by Odyssey Therapeutics (1882782) Subject | Form SCHEDULE 13D | |
| 05/13/2026 4:10 PM | COULTER JAMES G (1099776) Reporting Odyssey Therapeutics (1882782) Issuer TPG GP A, LLC (1903793) Reporting WINKELRIED JON (1366946) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/12/2026 4:37 PM | Dimension Capital II, L.P. (2040933) Reporting Odyssey Therapeutics (1882782) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/12/2026 4:36 PM | Dimension Capital II, L.P. (2040933) Reporting Odyssey Therapeutics (1882782) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 05/11/2026 8:11 PM | George Simeon (1595117) Reporting Odyssey Therapeutics (1882782) Issuer SR ONE CAPITAL MANAGEMENT, LLC (1853723) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ODTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Odyssey Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 05/11/2026 7:30 PM | Odyssey Therapeutics (1882782) Issuer Todd Collin M (2050088) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 7:30 PM | Odyssey Therapeutics (1882782) Issuer Opipari Anthony W. (2131341) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 7:30 PM | Glick Gary D (2051249) Reporting Odyssey Therapeutics (1882782) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 7:30 PM | Odyssey Therapeutics (1882782) Issuer Walbert Timothy P (1349376) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 7:30 PM | Dales Natalie (2130322) Reporting Odyssey Therapeutics (1882782) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 7:30 PM | Odyssey Therapeutics (1882782) Issuer Tatsis Ourania (1789815) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 7:30 PM | Chu Shelley (1895958) Reporting Odyssey Therapeutics (1882782) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 7:30 PM | Odegard Valerie (1832432) Reporting Odyssey Therapeutics (1882782) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 7:30 PM | Odyssey Therapeutics (1882782) Issuer SMITH IAN F (1197032) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 7:30 PM | Li Nan (0) LN Odyssey Therapeutics (1882782) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 7:32 PM | Haas Jason (1883821) Reporting Odyssey Therapeutics (1882782) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 7:35 PM | LEIDEN JEFFREY M (1242825) Reporting Odyssey Therapeutics (1882782) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/08/2026 3:45 PM | Odyssey Therapeutics (1882782) Filer | Form 424B4 | |
| 05/07/2026 11:15 PM | Odyssey Therapeutics (1882782) Filer | Form EFFECT | |
| 05/07/2026 8:39 PM | Odyssey Therapeutics (1882782) Issuer Tatsis Ourania (1789815) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/07/2026 8:40 PM | Odegard Valerie (1832432) Reporting Odyssey Therapeutics (1882782) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 05/07/2026 8:45 PM | Odyssey Therapeutics (1882782) Issuer Walbert Timothy P (1349376) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/07/2026 8:23 PM | COULTER JAMES G (1099776) Reporting Odyssey Therapeutics (1882782) Issuer TPG GP A, LLC (1903793) Reporting WINKELRIED JON (1366946) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/07/2026 8:23 PM | Odyssey Therapeutics (1882782) Issuer SMITH IAN F (1197032) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/07/2026 8:23 PM | Odyssey Therapeutics (1882782) Issuer Todd Collin M (2050088) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/07/2026 8:27 PM | Glick Gary D (2051249) Reporting Odyssey Therapeutics (1882782) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 05/07/2026 8:28 PM | George Simeon (1595117) Reporting Odyssey Therapeutics (1882782) Issuer SR ONE CAPITAL MANAGEMENT, LLC (1853723) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/07/2026 8:28 PM | LEIDEN JEFFREY M (1242825) Reporting Odyssey Therapeutics (1882782) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 05/07/2026 8:30 PM | Li Nan (0) LN Odyssey Therapeutics (1882782) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 05/07/2026 8:31 PM | Odyssey Therapeutics (1882782) Issuer Siegel Jolie (1768223) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/07/2026 8:31 PM | Odyssey Therapeutics (1882782) Issuer Opipari Anthony W. (2131341) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/07/2026 8:34 PM | Dales Natalie (2130322) Reporting Odyssey Therapeutics (1882782) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 05/07/2026 8:34 PM | Chu Shelley (1895958) Reporting Odyssey Therapeutics (1882782) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 05/07/2026 8:17 PM | Odyssey Therapeutics (1882782) Issuer Pavletic Aranicki Ksenija (2131727) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/07/2026 8:21 PM | Hill Paulina (1710965) Reporting Odyssey Therapeutics (1882782) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
Stranded On The Flood Plains of History (Ad) The petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed U.S. Treasury holdings by 45% from peak, and central banks are swapping dollars for gold at the fastest pace since the Cold War.
Porter Stansberry believes Trump is channeling more than $3 trillion toward securing the minerals, chips, and infrastructure that make AI possible - and companies at those chokepoints like Vertiv (up 500%), GE Vernova (up 700%), and Arista Networks (up 750%) are already moving.
Porter's new briefing names one asset to buy today plus five stocks positioned at the narrowest chokepoints of what he calls the Silicon Dollar. Read Porter's full briefing and get the ticker names today |
| 05/07/2026 8:22 PM | NG CAROLYN (1777346) Reporting Odyssey Therapeutics (1882782) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 05/07/2026 8:22 PM | Haas Jason (1883821) Reporting Odyssey Therapeutics (1882782) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 05/07/2026 7:28 PM | Odyssey Therapeutics (1882782) Filer | Form S-1MEF | |
| 05/07/2026 2:12 PM | Odyssey Therapeutics (1882782) Filer | Form CERT | |
| 05/05/2026 12:00 PM | Odyssey Therapeutics (1882782) Filer | Form 8-A12B | |
| 05/04/2026 5:05 AM | Odyssey Therapeutics (1882782) Filer | Form S-1/A | |
| 04/17/2026 3:05 PM | Odyssey Therapeutics (1882782) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 12/04/2025 1:51 PM | Odyssey Therapeutics (1882782) Filer | Form D Notice of Exempt Offering of Securities | |